相关实验视频

Updated: Sep 16, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K

[成熟B细胞新生瘤的CAR T细胞疗法-当前使用和实际考虑]

Theresa Weber1, Andreas Burchert2, Marion Subklewe3

  • 1Universitätsklinikum Gießen und Marburg, Campus Marburg, Klinik für Hämatologie, Onkologie und Immunologie, Carreras Leukämie Centrum, Philipps-Universität Marburg, Baldingerstr., 35043, Marburg, Deutschland.

Innere Medizin (Heidelberg, Germany)
|July 11, 2025
PubMed
概括

化学抗原受体 (CAR) T细胞疗法为成熟的B细胞瘤 (如淋巴瘤) 提供了高度有效的治疗方法. 仔细的患者选择和毒性管理对于这种先进的免疫治疗成功的结果至关重要.

关键词:
卡尔-T细胞疗法/后期护理细胞因子释放综合征 细胞因子释放综合征淋巴瘤,毛囊性淋巴瘤,毛囊性淋巴瘤淋巴瘤,大B细胞淋巴瘤淋巴瘤,地幔细胞淋巴瘤

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

811
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665